Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017

In 2008, the National Institute of Health and Care Excellence in the UK recommended that patients undergoing lipoprotein apheresis (LA) should be included in an anonymised registry. The UK Lipoprotein Apheresis Registry was subsequently established in 2011. Between 2011 and 2017, data was entered re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Atherosclerosis 2019-11, Vol.290, p.44-51
Hauptverfasser:	Pottle, Alison, Thompson, Gilbert, Barbir, Mahmoud, Bayly, Graham, Cegla, Jaimini, Cramb, Robert, Dawson, Tina, Eatough, Ruth, Kale, Vaishali, Neuwirth, Clare, Nicholson, Kirsty, Payne, Jules, Scott, James, Soran, Handrean, Walji, Shahenaz, Watkins, Suzanne, Weedon, Hazel, Nath Datta, Dev Borunendra
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular events Heterozygous familial hypercholesterolaemia Homozygous familial hypercholesterolaemia Lipoprotein (a) Lipoprotein apheresis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!